mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, enters into the cryptocurrency market, partnering with Render Payment during its Pre-ICO (Initial Coin Offering).
Marijuana Investing
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids
Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology.
Organigram Expanding Operations, Hiring Up To 140 New Employees, Will Raise Annual Output to 25,000 kg
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) is undergoing a production-facility expansion that will more than triple the size of its operations. The multi-million-dollar project will meet the growing needs of the Company’s medical patient base, as well as prepare Organigram for the legal, adult-recreational marijuana market.
InMed Pharmaceuticals pursues medical qualities of cannabis — no smoke
People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.
BC Bud. BC Tweed. Canopy Growth establishes joint venture to convert 1.3 million square feet of existing greenhouse in British Columbia
BC Bud. BC Tweed. Canopy Growth establishes joint venture to convert 1.3 million square feet of existing greenhouse in British Columbia. The joint venture includes an option for additional 1.7 Million sq. ft. greenhouse.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scales Up in Preparation for Canada’s Impending 2018 Recreational Cannabis Legalization
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date.
ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care
Further scientific validation will be icing on the cake for ChineseInvestors.com, Inc. (OTCQB: CIIX).
India Globalization Capital (NYSE: IGC) Announces Significant Breakthrough that Could Potentially Prevent, Fight Alzheimer’s Disease
India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease.
ChineseInvestors.com, Inc. (CIIX) Launches Cryptocurrency Daily Video Newscast
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of the first cryptocurrency daily video newscast in the Chinese language broadcast from the NYSE.
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announces the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Maccarrone has vast experience in the field of cannabinoid research.
PotNetwork Holding, Inc. (POTN) Announces Appointment of Dr. Michael McKenzie to Advisory Board
PotNetwork Holding, Inc. (OTC: POTN) this morning announced its appointment of Dr. Michael McKenzie, an industry-leading physician, to its advisory board.
SeeThruEquity Issues Update on ChineseInvestors.com, Inc. (CIIX)
SeeThruEquity has updated its coverage and maintained its price target of $3.75 on shares of ChineseInvestors.com, Inc.’s (OTCQB: CIIX) stock.
India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent.
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) Files Provisional Patent for Pain Program
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has more major news today as they have filed a provisional patent for pain program. This is a huge step in protecting intellectual and commercial property related to their groundbreaking research into the potential of non-THC cannabinoids to treat pain using a topical formulation..
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More
Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action.